Symphony Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,251
Closed -$1.71M 193
2018
Q2
$1.71M Sell
6,251
-1,009
-14% -$284K 0.34% 64
2018
Q1
$1.99M Sell
7,260
-3,237
-31% -$1M 0.26% 94
2017
Q4
$3.34M Sell
10,497
-44
-0.4% -$14.1K 0.34% 69
2017
Q3
$3.3M Sell
10,541
-504
-5% -$149K 0.37% 67
2017
Q2
$3M Buy
11,045
+5,271
+91% +$1.39M 0.34% 72
2017
Q1
$1.58M Buy
5,774
+212
+4% +$59.9K 0.15% 148
2016
Q4
$1.58M Buy
5,562
+403
+8% +$119K 0.16% 141
2016
Q3
$1.61M Sell
5,159
-275
-5% -$81.4K 0.16% 144
2016
Q2
$1.31M Sell
5,434
-770
-12% -$203K 0.14% 157
2016
Q1
$1.61M Buy
6,204
+1,543
+33% +$408K 0.18% 137
2015
Q4
$1.43M Sell
4,661
-83
-2% -$23.9K 0.16% 150
2015
Q3
$1.38M Sell
4,744
-1,028
-18% -$339K 0.17% 144
2015
Q2
$2.33M Buy
5,772
+976
+20% +$392K 0.29% 90
2015
Q1
$2.02M Sell
4,796
-547
-10% -$216K 0.24% 99
2014
Q4
$1.81M Sell
5,343
-1,048
-16% -$339K 0.23% 110
2014
Q3
$2.12M Sell
6,391
-3,548
-36% -$1.17M 0.22% 96
2014
Q2
$3.13M Sell
9,939
-1,449
-13% -$436K 0.33% 88
2014
Q1
$3.48M Buy
11,388
+2,541
+29% +$807K 0.33% 80
2013
Q4
$2.47M Buy
8,847
+1,447
+20% +$374K 0.19% 115
2013
Q3
$1.78M Buy
7,400
+412
+6% +$92.2K 0.18% 127
2013
Q2
$1.5M Buy
+6,988
New +$1.49M 0.15% 140

Other funds holding BIIB